Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 18 Issue: 4, May 2018

Meet Our Editorial Board Member free to download

Volume:18   Issue: 4
Pp: 305-305
M. Haber
DOI: 10.2174/156800961804180406165916
Published on: 06 April, 2018

Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer

Volume:18   Issue: 4
Pp: 306-327
Heena Singla, Anjana Munshi*, Raja Paramjit Singh Banipal and Vinod Kumar*
DOI: 10.2174/1568009617666170623122213
Published on: 23 June, 2017

Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy

Volume:18   Issue: 4
Pp: 328-336
Shirin Eyvazi, Bahram Kazemi, Siavoush Dastmalchi* and Mojgan Bandehpour*
DOI: 10.2174/1570163814666170818125036
Published on: 18 August, 2017

Synthetic Lethality: From Research to Precision Cancer Nanomedicine

Volume:18   Issue: 4
Pp: 337-346
Anuradha Gupta, Anas Ahmad, Aqib Iqbal Dar and Rehan Khan*
DOI: 10.2174/1568009617666170630141931
Published on: 30 June, 2017

Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy

Volume:18   Issue: 4
Pp: 347-354
Xinyi Wang, Haiyang Zhang, Haiou Yang, Ming Bai, Tao Ning, Shuang Li, Jialu Li, Ting Deng, Guoguang Ying* and Yi Ba*
DOI: 10.2174/1568009617666170710120311
Published on: 10 July, 2017

The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations

Volume:18   Issue: 4
Pp: 355-364
Dearbhaile C. Collins, Maxime Chenard-Poirier and Juanita S. Lopez*
DOI: 10.2174/1568009617666170927114440
Published on: 27 September, 2017

Chemosensitizing Activity of Histone Deacetylases Inhibitory Cyclic Hydroxamic Acids for Combination Chemotherapy of Lymphatic Leukemia

Volume:18   Issue: 4
Pp: 365-371
Denis V. Mishchenko, Margarita E. Neganova, Elena N. Klimanova, Tatyana E. Sashenkova, Sergey G. Klochkov, Elena F. Shevtsova, Igor V. Vystorop, Vadim V. Tarasov, Vladimir N. Chubarev, Anna N. Samsonova, Ghulam Md Ashraf, George Barreto, Nagendra Sastry Yarla and Gjumrakch Aliev*
DOI: 10.2174/1568009617666170623104030
Published on: 22 June, 2017

DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma

Volume:18   Issue: 4
Pp: 372-381
Magda F. Mohamed, Amr Mohamed Abdelmoniem, Ahmed H.M. Elwahy* and Ismail A. Abdelhamid*
DOI: 10.2174/1568009617666170630143311
Published on: 30 June, 2017

FOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer

Volume:18   Issue: 4
Pp: 382-389
Jiali Wu, Peng Liu, Hailin Tang, Zeyu Shuang, Qingsheng Qiu, Lijuan Zhang, Cailu Song, Lingrui Liu, Xiaoming Xie* and Xiangsheng Xiao*
DOI: 10.2174/1568009618666180131115356
Published on: 30 January, 2018

Neoisoliquiritigenin Inhibits Tumor Progression by Targeting GRP78-β- catenin Signaling in Breast Cancer

Volume:18   Issue: 4
Pp: 390-399
Hailin Tang, Fu Peng, Xiaojia Huang, Xinhua Xie, Bo Chen, Jiangang Shen, Fei Gao, Jieshu You, Xiaoming Xie* and Jianping Chen*
DOI: 10.2174/1568009617666170914155355
Published on: 14 September, 2017